Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Rausch

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Deutsches Arzteblatt International|June 13, 2012
Cataract surgery in patients taking alpha-1 antagonists: know the risks, avoid the complicationsDaniel M Handzel, Sebastian Briesen, Steffen Rausch, et al.
Cancers|June 24, 2022
Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus NivolumabViktoria Stühler, Lisa Herrmann, Steffen Rausch, et al.
Future Oncology (London, England)|June 25, 2020
Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trialValentina Norz, Laura Lawaczeck, Jens Bedke, et al.
Kidney & Blood Pressure Research|May 4, 2025
Thromboxane A2 or activated platelets slightly low-er Fgf23 expression in vitroElena Kohm, Steffen Rausch, Julia Vogt, et al.
Expert Review of Anticancer Therapy|May 6, 2024
The role of planetary health in urologic oncologyLaura Lawaczeck, Julia Rudolph, Valentina Norz, et al.
Medical Ultrasonography|September 8, 2012
The utility of transrectal sonoelastography in preoperative prostate cancer assessmentSteffen Rausch, Wibke Alt, Hartmut Arps, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 14, 2016
Metastasectomy for metastatic renal cell carcinoma in the era of modern systemic treatment: C-reactive protein is an independent predictor of overall survivalSteffen Rausch, Stephan Kruck, Kerstin Walter, et al.
Therapeutic Advances in Urology|April 18, 2018
Optical improvements in the diagnosis of bladder cancer: implications for clinical practiceTina Schubert, Steffen Rausch, Omar Fahmy, et al.
Journal of Cancer Research and Clinical Oncology|July 30, 2022
Real world data on IO-based therapy for metastatic renal cell carcinomaViktoria Stühler, Lisa Herrmann, Steffen Rausch, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 19, 2024
Bilirubin Down-Regulates Oxidative Stress and Fibroblast Growth Factor 23 Expression in UMR106 Osteoblast-Like CellsSteffen Rausch, Katharina Hammerschmidt, Martina Feger, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Deutsches Arzteblatt International|June 13, 2012
Cataract surgery in patients taking alpha-1 antagonists: know the risks, avoid the complicationsDaniel M Handzel, Sebastian Briesen, Steffen Rausch, et al.
Cancers|June 24, 2022
Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus NivolumabViktoria Stühler, Lisa Herrmann, Steffen Rausch, et al.
Future Oncology (London, England)|June 25, 2020
Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trialValentina Norz, Laura Lawaczeck, Jens Bedke, et al.
Kidney & Blood Pressure Research|May 4, 2025
Thromboxane A2 or activated platelets slightly low-er Fgf23 expression in vitroElena Kohm, Steffen Rausch, Julia Vogt, et al.
Expert Review of Anticancer Therapy|May 6, 2024
The role of planetary health in urologic oncologyLaura Lawaczeck, Julia Rudolph, Valentina Norz, et al.
Medical Ultrasonography|September 8, 2012
The utility of transrectal sonoelastography in preoperative prostate cancer assessmentSteffen Rausch, Wibke Alt, Hartmut Arps, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 14, 2016
Metastasectomy for metastatic renal cell carcinoma in the era of modern systemic treatment: C-reactive protein is an independent predictor of overall survivalSteffen Rausch, Stephan Kruck, Kerstin Walter, et al.
Therapeutic Advances in Urology|April 18, 2018
Optical improvements in the diagnosis of bladder cancer: implications for clinical practiceTina Schubert, Steffen Rausch, Omar Fahmy, et al.
Journal of Cancer Research and Clinical Oncology|July 30, 2022
Real world data on IO-based therapy for metastatic renal cell carcinomaViktoria Stühler, Lisa Herrmann, Steffen Rausch, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 19, 2024
Bilirubin Down-Regulates Oxidative Stress and Fibroblast Growth Factor 23 Expression in UMR106 Osteoblast-Like CellsSteffen Rausch, Katharina Hammerschmidt, Martina Feger, et al.
Pageof 13